HumanN   Report issue

For profit Phase 2
Founded: Austin TX United States (2009)
Status: No NME R&D (2009)

Organization Overview

First Clinical Trial
2012
NCT01710761
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Alternative names

HumanN | Neogenis Laboratories

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Hypertension (Phase 2)

Prehypertension (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 7
  • # of Trial APIs: 9